Afatinib, an EGFR inhibitor, decreases EMT and tumorigenesis of Huh‑7 cells by regulating the ERK‑VEGF/MMP9 signaling pathway

Yafei Chen(The First People's Hospital of Tianmen), Yingwei Wang(Ministry of Education and Child Care)
Molecular Medicine Reports
August 6, 2019
Cited by 37


Related Papers